First Time Loading...

OptiNose Inc
NASDAQ:OPTN

Watchlist Manager
OptiNose Inc Logo
OptiNose Inc
NASDAQ:OPTN
Watchlist
Price: 1.01 USD 15.09% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

OPTN Price Targets Summary
OptiNose Inc

Wall Street analysts forecast OPTN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OPTN is 3.83 USD with a low forecast of 3.03 USD and a high forecast of 5.25 USD.

OPTN Lowest Forecast
Wall Street Target
3.03 USD
200% Upside
OPTN Average Forecast
Wall Street Target
3.83 USD
279% Upside
OPTN Highest Forecast
Wall Street Target
5.25 USD
420% Upside
Lowest
Price Target
3.03 USD
200% Upside
Average
Price Target
3.83 USD
279% Upside
Highest
Price Target
5.25 USD
420% Upside
OptiNose Inc Competitors:
Price Targets
600420
Shanghai Shyndec Pharmaceutical Co Ltd
57% Upside
C
CLN
Celon Pharma SA
2% Downside
4569
Kyorin Holdings Inc
3% Downside
b
BTMD
biote Corp
47% Upside
600420
Shanghai Shyndec Pharmaceutical Co Ltd
57% Upside
C
CLN
Celon Pharma SA
2% Downside
4569
Kyorin Holdings Inc
3% Downside
b
BTMD
biote Corp
47% Upside
600195
China Animal Husbandry Industry Co Ltd
38% Upside
NECLIFE
Nectar Lifesciences Ltd
22% Upside
G
605507
Guobang Pharma Ltd
47% Upside
4581
Taisho Pharmaceutical Holdings Co Ltd
99% Downside

Revenue
Forecast

Revenue Estimate
OptiNose Inc

For the last 7 years the compound annual growth rate for OptiNose Inc's revenue is 6%. The projected CAGR for the next 3 years is 31%.

6%
Past Growth
31%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
OptiNose Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
OptiNose Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-58%
Average Miss
What are analyst estimates?

See Also

Summary
OPTN intrinsic value, competitors valuation, and company profile.
DCF Valuation
OPTN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OPTN stock valuation using valuation multiples.
Wall Street Estimates
OPTN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OPTN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OPTN's stock price target?
Price Target
3.83 USD

According to Wall Street analysts, the average 1-year price target for OPTN is 3.83 USD with a low forecast of 3.03 USD and a high forecast of 5.25 USD.

What is OptiNose Inc's Revenue forecast?
Projected CAGR
31%

For the last 7 years the compound annual growth rate for OptiNose Inc's revenue is 6%. The projected CAGR for the next 3 years is 31%.

ALPHA SPREAD
Join more than 134,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.